Investors in Venture Capita

We believe the world's biggest challenges can be tackled by combining breakthrough technologies and global collaboration. We invest in the health of people and the planet with the goal of generating sustainable value and leaving a better world for future generations. ‍ Courageous missions are essential and teams tackling these challenges need access to big markets, the support of a like-minded community and investors who aren't afraid to take risks and fund big visions early on. That is why DART is here. ‍ DART is woven into the U.S, and Swiss ecosystems and connects the best of both.

Carbon Removal Partners is a Zurich-based VC with a pure focus on the growing Carbon Removal industry. Carbon Removal Partners invests into technologies to withdraw carbon from the atmosphere in a permanent manner, as well as into companies along the Carbon Removal value chain. It is our goal to collaborate with the most ambitious entrepreneurs in the industry to make the need of reversing humanity's carbon streams become a reality. Carbon Removal Partners takes decisions with regards to its deepest conviction that carbon removal will take on an indispensable role among other carbon reduction strategies. Well aware of today's challenges we seek to enable systemic change.

Swiss Founders Fund AG is a management holding and seed stage venture capital investment fund based in St.Gallen, Switzerland. Unlike traditional VCs, SFF focuses on incubating own ventures with a long-term perspective. Focus industries include education, mobile, travel, e-commerce, publishing; investments are mainly done in Europe and Asia Pacific. SFF invests into seed & early-stage tech startups with a focus on PropTech, Hospitality, Exponential Technologies & DLT.

We believe in the power of climate neutral economic development in Africa. For the last decade, we have been working hand in hand with exceptional entrepreneurs, investing both financial and human capital to build successful climate ventures on the continent. Our companies offer competitive financial returns required to drive lasting impact.

As a student-run venture capital fund, we provide students from Swiss higher education with personalized feedback and support, demystify the funding process, and invest 25'000 CHF in their startups. Vision Educating the next generation of investors that make an impact on the ecosystem and give rise to breakthrough ideas of the next generation. Mission Fostering a cross-campus culture, diversity, and boldness to bring change into society by backing breakthrough ideas coming out of the universities. We see it as a strength that the student-run team changes every 1-2 years as it enables us to touch more people and disseminate the impact into the world.

For over forty years, we have been providing capital support to startups, SMEs, and mid-sized companies, enabling them to grow, innovate, and transform. As a subsidiary of Crédit Mutuel Alliance Fédérale, France's leading "mission-based bank," we believe in giving entrepreneurs the necessary time to achieve their vision. Alongside them, we invest our own funds (€4 billion), which provides us with the flexibility and autonomy to support them over the long term. Each of the 350 companies we support is unique in terms of size, sector, maturity, project, and culture.

We support the builders of critical Web3 infrastructure. We help design products, protocols, and tokens. We are technical and hands-on investors with roots in Europe.

Bridging the gap between disruptive discovery products and real-world patient reach, we identify high-potential compounds for in-licensing, we conduct clinical development and then select large pharmaceutical commercialization partners for out-licensing to maximize patient access across the globe. Through this specialized business model, Debiopharm can focus on the development of prescription drugs that target unmet medical needs in oncology and bacterial infections. Debiopharm is an independent biopharmaceutical company based in Switzerland with an ongoing commitment to develop tomorrow’s standard of care to cure cancer & infectious diseases and improve patient quality of life.

At AFI Ventures, we are committed to supporting the most promising seed and pre-seed impact entrepreneurs. From climate action to promoting healthy living, we partner with every visionary who shares our ambition for deep, scalable impact. We invest up to €500k in 1 to 2 companies every month, empowering these entrepreneurs to achieve their goals. AFI Ventures serves as the seed fund of Alliance for Impact, Europe's leading impact launchpad. How can our support help drive your impactful vision forward?

An early-stage venture capital investment firm.Black Capital Ventures is a high-tech startup advisory partner and green venture capital fund dedicated to investing in a better world. Specializing in GreenTech and MedTech startups, we provide strategic growth support, tools, insights, and a network.

We invest in innovative private early- to mid-stage human Life Science companies that address important medical needs with novel technologies or products backed by compelling science and with differentiated advantages over current treatment options. Our focus is on Switzerland and surrounding EU countries Germany, Austria, France, Italy and Benelux. We mostly invest in drug development and, to a lesser degree, in diagnostics and medical technology. The amount we aim to invest over the life time of our portfolio companies is up to CHF 10 million.

European Internet Ventures is an internet advisory firm focused on online classifieds and marketplaces. Funding Growth EIV raises growth capital for fast-growing marketplace businesses. We work on Series A and all later rounds, with some transactions exceeding $100 million. Full or Partial Exits​ We arrange exits to financial buyers, such as PE and investment funds with strong marketplace credentials, and we find strategic buyers and structure cash and earn-out deals. M&A We support strategic and financial buyers by finding targets, performing due diligence and running the transaction process.